Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chytridiomycota is a **phylum of fungi** characterized by producing motile zoospores with a single posterior whiplash flagellum. Members are commonly known as chytrids and are among the most primitive true fungi. They are primarily found in aquatic environments or moist soils and play essential roles as decomposers (saprobes), breaking down refractory materials like chitin and keratin, thus contributing to nutrient cycling[1][5][9]. Some species act as parasites on algae, plants, insects, or amphibians; for example, *Batrachochytrium dendrobatidis* is responsible for chytridiomycosis—a disease implicated in global amphibian population declines[1][5][9]. Chytrids can be unicellular or form simple multicellular structures without septa between cells. Their evolutionary significance lies in their position as one of the earliest diverging fungal lineages[2]. **Note:** "Chytridiomycota fungus" refers to an entire fungal phylum rather than a specific molecular target such as a receptor or enzyme. Therefore, it is not considered a therapeutic target but rather an organismal group containing many different potential targets within its member species. If you seek information about druggable targets related to diseases caused by chytrid fungi (e.g., proteins from *Batrachochytrium dendrobatidis*), please specify the particular molecule or protein of interest[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chytridiomycota.